🔎 Trials Near Me

Akèy › Skleroz an milti relaps-remitan › Illinois

Etid klinik pou Skleroz an milti relaps-remitan nan Illinois

6 etid pou Skleroz an milti relaps-remitan ap chèche patisipan nan sit nan Illinois.

Vil nan Illinois

Tèks ofisyèl etid la (Anglè)

Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

  • Northwestern University, Evanston
Ap rekriteFaz 3
Laj 18 a 55 · Tout sèks · Mizajou Sep 16, 2026 · NCT04047628

Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis

  • University of Chicago Medical Center, Chicago
Ap rekriteFaz 3
Laj 10 a 17 · Tout sèks · Mizajou Sep 10, 2026 · NCT06408259

Intermittent Hypoxia in Persons With Multiple Sclerosis

  • Shirley Ryan AbilityLab, Chicago
Ap rekrite
Laj 18 a 75 · Tout sèks · Mizajou Mar 20, 2026 · NCT06276634

Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis

  • Northwestern Memorial Hospital, Chicago
Ap rekriteFaz 4
Laj 18 a 70 · Tout sèks · Mizajou Mar 17, 2026 · NCT07225361

Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS

  • Shirley Ryan AbilityLab, Chicago
Ap rekrite
Laj 18 a 75 · Tout sèks · Mizajou Feb 23, 2026 · NCT06390930

Home Based Functional Balance Intervention for Multiple Sclerosis

  • University of Illinois at Chicago, Chicago
Ap rekrite
Laj 40 a 90 · Tout sèks · Mizajou Jan 21, 2026 · NCT07355387

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.